Mark Bonnen

4.6k total citations · 1 hit paper
45 papers, 1.7k citations indexed

About

Mark Bonnen is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Mark Bonnen has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 13 papers in Radiation and 10 papers in Surgery. Recurrent topics in Mark Bonnen's work include Advanced Radiotherapy Techniques (13 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Mark Bonnen is often cited by papers focused on Advanced Radiotherapy Techniques (13 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Mark Bonnen collaborates with scholars based in United States, Brazil and China. Mark Bonnen's co-authors include Radhe Mohan, Bouthaina S. Dabaja, Barbara Pro, Jaffer A. Ajani, Dima Suki, Lei Dong, J OˈDaniel, Deborah A. Kuban, Rex Cheung and Adam S. Garden and has published in prestigious journals such as Cancer, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Mark Bonnen

41 papers receiving 1.7k citations

Hit Papers

Validation of an accelera... 2005 2026 2012 2019 2005 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark Bonnen 722 569 512 491 471 45 1.7k
Ivan Weng Keong Tham 775 1.1× 789 1.4× 232 0.5× 665 1.4× 737 1.6× 66 2.2k
Serena Monti 376 0.5× 145 0.3× 284 0.6× 891 1.8× 194 0.4× 93 1.4k
Servet Tatlı 663 0.9× 517 0.9× 83 0.2× 574 1.2× 363 0.8× 64 1.7k
Koert F.D. Kuhlmann 506 0.7× 770 1.4× 71 0.1× 263 0.5× 996 2.1× 76 1.6k
Irene M. Lips 757 1.0× 448 0.8× 436 0.9× 518 1.1× 211 0.4× 41 1.4k
Franca Melfi 2.3k 3.2× 1.1k 1.9× 297 0.6× 302 0.6× 532 1.1× 162 3.6k
Francesco Giganti 3.1k 4.3× 574 1.0× 82 0.2× 2.2k 4.5× 335 0.7× 105 4.1k
Stefan Diederich 1.8k 2.5× 319 0.6× 108 0.2× 1.6k 3.2× 235 0.5× 103 2.7k
Roger Sun 706 1.0× 300 0.5× 87 0.2× 1.7k 3.4× 792 1.7× 67 2.3k
John B. Martinie 753 1.0× 1.3k 2.2× 56 0.1× 168 0.3× 1.0k 2.2× 166 2.3k

Countries citing papers authored by Mark Bonnen

Since Specialization
Citations

This map shows the geographic impact of Mark Bonnen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bonnen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bonnen more than expected).

Fields of papers citing papers by Mark Bonnen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bonnen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bonnen. The network helps show where Mark Bonnen may publish in the future.

Co-authorship network of co-authors of Mark Bonnen

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Bonnen. A scholar is included among the top collaborators of Mark Bonnen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Bonnen. Mark Bonnen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Martin, Thomas R., Daniel Saenz, Pamela Myers, et al.. (2023). Dosimetric characterization of a new surface‐conforming electron MLC prototype. Journal of Applied Clinical Medical Physics. 25(2). e14173–e14173. 2 indexed citations
3.
Bonnen, Mark, et al.. (2023). Computational approaches for drug repurposing in oncology: untapped opportunity for high value innovation. Frontiers in Oncology. 13. 1198284–1198284. 8 indexed citations
4.
Ebrahimpour, Afshin, Manisha Ahir, Min Wang, et al.. (2022). Combination of esomeprazole and pirfenidone enhances antifibrotic efficacy in vitro and in a mouse model of TGFβ-induced lung fibrosis. Scientific Reports. 12(1). 20668–20668. 9 indexed citations
5.
Bonnen, Mark, et al.. (2022). Proton pump inhibitors and sensitization of cancer cells to radiation therapy. Frontiers in Oncology. 12. 937166–937166. 5 indexed citations
6.
Ebrahimpour, Afshin, Min Wang, Li Li, et al.. (2021). Esomeprazole attenuates inflammatory and fibrotic response in lung cells through the MAPK/Nrf2/HO1 pathway. Journal of Inflammation. 18(1). 17–17. 13 indexed citations
7.
Bonnen, Mark, et al.. (2020). Non-invasive stereotactic ablative boost in patients with locally advanced cervical cancer. International Journal of Gynecological Cancer. 30(11). 1684–1688. 8 indexed citations
8.
Bakhshaie, Jafar, Mark Bonnen, Joshua Asper, Vlad C. Sandulache, & Hoda Badr. (2019). Emotional disclosure and cognitive processing in couples coping with head and neck cancer. Journal of Behavioral Medicine. 43(3). 411–425. 7 indexed citations
9.
Badr, Hoda, Krista Herbert, Mark Bonnen, Joshua Asper, & Timothy Wagner. (2018). Dyadic Coping in Patients Undergoing Radiotherapy for Head and Neck Cancer and Their Spouses. Frontiers in Psychology. 9. 1780–1780. 34 indexed citations
10.
Ebrahimpour, Afshin, et al.. (2018). Nicotine Modulates Growth Factors and MicroRNA to Promote Inflammatory and Fibrotic Processes. Journal of Pharmacology and Experimental Therapeutics. 368(2). 169–178. 28 indexed citations
11.
Hanania, Alexander N., Pamela Myers, Zhiqian Yu, et al.. (2018). Inversely and adaptively planned interstitial brachytherapy: A single implant approach. Gynecologic Oncology. 152(2). 353–360. 6 indexed citations
12.
Asper, Joshua, et al.. (2017). Factors Associated With Radiation Treatment Compliance for Women With Cervical Cancer in a Safety Net Health System. International Journal of Gynecological Cancer. 27(7). 1464–1471. 5 indexed citations
13.
Nelson, Christina, Kang Ko, Andrew G. Sikora, et al.. (2017). Therapeutic Efficacy of Esomeprazole in Cotton Smoke-Induced Lung Injury Model. Frontiers in Pharmacology. 8. 16–16. 25 indexed citations
14.
Ludwig, Michelle, et al.. (2016). Compliance to Radiation Therapy for Head and Neck Cancer in a Safety-Net Health System. International Journal of Radiation Oncology*Biology*Physics. 94(4). 913–914. 1 indexed citations
15.
Macdonald, Andrew, et al.. (2015). Treatment Compliance and Outcomes for Women With Locoregionally Advanced Cervical Cancer Treated in a Safety Net Health System. International Journal of Gynecological Cancer. 25(9). 1669–1676. 8 indexed citations
16.
Oh, Julia, Mark Bonnen, Elesyia D. Outlaw, et al.. (2006). The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is “young”?. International Journal of Radiation Oncology*Biology*Physics. 65(5). 1345–1352. 44 indexed citations
17.
Court, Laurence E., Lei Dong, Andrew K. Lee, et al.. (2005). An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 62(1). 154–163. 110 indexed citations
18.
Bonnen, Mark, Matthew T. Ballo, Jeffrey N. Myers, et al.. (2004). Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck. Cancer. 100(2). 383–389. 46 indexed citations
19.
Dabaja, Bouthaina S., Dima Suki, Barbara Pro, Mark Bonnen, & Jaffer A. Ajani. (2004). Adenocarcinoma of the small bowel. Cancer. 101(3). 518–526. 356 indexed citations
20.
Ballo, Matthew T., Mark Bonnen, Adam S. Garden, et al.. (2003). Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer. 97(7). 1789–1796. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026